TRMU Gene Mitochondrial Modifier of Deafness Genetic Test
Welcome to DNA Labs UAE, where we offer the TRMU Gene Mitochondrial Modifier of Deafness Genetic Test. This test helps diagnose the genetic cause of hearing loss and provides information for personalized treatment or management options.
Test Details
The TRMU gene is a mitochondrial modifier of deafness. It is responsible for encoding a protein that plays a role in the synthesis of mitochondrial transfer RNA (tRNA) molecules. Mutations in the TRMU gene can lead to a decrease in the stability and functionality of mitochondrial tRNA, which can ultimately result in hearing loss or deafness.
The NGS (Next-Generation Sequencing) genetic test is a type of genetic test that uses high-throughput sequencing technology to analyze multiple genes simultaneously. In the case of the TRMU gene, the NGS genetic test can identify any mutations or variants within the gene that may be associated with deafness.
Test Components and Price
- Test Name: TRMU Gene Mitochondrial Modifier of Deafness Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Ear Nose Throat Disorders
- Doctor: ENT Doctor
- Test Department: Genetics
Pre Test Information
Prior to taking the TRMU Gene Mitochondrial Modifier of Deafness Genetic Test, it is important to provide the clinical history of the patient who is going for the test. This includes information about CATSPER2 Gene Deafness and male infertility, as well as any related genetic tests. A genetic counseling session may also be conducted to draw a pedigree chart of family members affected with CATSPER2 Gene Deafness and male infertility.
Conclusion
Genetic testing, such as the TRMU Gene Mitochondrial Modifier of Deafness Genetic Test, can provide valuable information about the genetic cause of hearing loss. It is essential to undergo genetic testing under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate recommendations for personalized treatment or management options.
| Test Name | TRMU Gene Mitochondrial modifier of deafness Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ear Nose Throat Disorders |
| Doctor | ENT Doctor |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test gene CATSPER15 |
| Test Details |
The TRMU gene is a mitochondrial modifier of deafness. It is responsible for encoding a protein that plays a role in the synthesis of mitochondrial transfer RNA (tRNA) molecules. Mutations in the TRMU gene can lead to a decrease in the stability and functionality of mitochondrial tRNA, which can ultimately result in hearing loss or deafness. The NGS (Next-Generation Sequencing) genetic test is a type of genetic test that uses high-throughput sequencing technology to analyze multiple genes simultaneously. In the case of the TRMU gene, the NGS genetic test can identify any mutations or variants within the gene that may be associated with deafness. This test can help diagnose the genetic cause of hearing loss and provide information for personalized treatment or management options. It is important to note that genetic testing should be done under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate recommendations. |
